These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 3379369)

  • 41. Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study.
    Tomasik T; Jozwiak J; Windak A; Rygiel K; Mastej M; Smithson WH; Mathers N; Tomaszewski M; Kaess BM; Tykarski A; Konduracka E; Grzeszczak W; Lukas W
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):287-96. PubMed ID: 21450675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lowering cholesterol with drugs and diet.
    Pedersen TR
    N Engl J Med; 1995 Nov; 333(20):1350-1. PubMed ID: 7566029
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hypercholesterolemia and coronary disease: intervention strategies].
    Brunelli C; Spallarossa P; Saccani A; Corsiglia L; Ghigliotti G; Caponnetto S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):303-8. PubMed ID: 1841785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Step management of hypercholesterolemia.
    Repka FJ; Leighton RF
    Am Fam Physician; 1987 Oct; 36(4):238-48. PubMed ID: 3314439
    [No Abstract]   [Full Text] [Related]  

  • 46. [Methodology of phase III clinical trials of hypocholesteremic agents. Do any reliable substitution criteria exist?].
    Espié J
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():121-4. PubMed ID: 1285690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What are the priorities for managing cholesterol effectively?
    Brown WV
    Am J Cardiol; 2001 Aug; 88(4A):21F-4F. PubMed ID: 11520483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
    Labreche DG
    Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention. Who should take cholesterol-lowering drugs?
    Harv Health Lett; 1998 Jan; 23(3):1-3. PubMed ID: 9650517
    [No Abstract]   [Full Text] [Related]  

  • 50. Cholesterol. Interpreting the new guidelines.
    Becker DM; LaRosa JH; Watson JE
    Am J Nurs; 1989 Dec; 89(12):1621-4. PubMed ID: 2589418
    [No Abstract]   [Full Text] [Related]  

  • 51. [The cholesterol question. Disinformed information].
    Bobbio M; Brusca A
    G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828
    [No Abstract]   [Full Text] [Related]  

  • 52. Unresolved issues in early trials of cholesterol lowering.
    LaRosa JC
    Am J Cardiol; 1995 Sep; 76(9):5C-9C. PubMed ID: 7572687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attitudes and practices of primary care physicians in the management of elevated serum cholesterol levels.
    Langner NR; Hasselback PD; Dunkley GC; Corber SJ
    CMAJ; 1989 Jul; 141(1):33-8. PubMed ID: 2731100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for high blood cholesterol. U.S. Preventive Services Task Force.
    Am Fam Physician; 1990 Feb; 41(2):503-13. PubMed ID: 2405605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.
    Aronow WS; Ahn C
    Am J Cardiol; 2002 Jan; 89(1):67-9. PubMed ID: 11779527
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

  • 57. Preventive cardiology.
    Reeves WC
    Med Sect Proc; 1989; ():29-37. PubMed ID: 2701587
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cholesterol--the main risk factor in ischemic heart disease].
    Heyden S; Kroos S
    Schweiz Rundsch Med Prax; 1988 Nov; 77(48):1312-7. PubMed ID: 3064242
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapy and clinical trials.
    Feher MD
    Curr Opin Lipidol; 1996 Dec; 7(6):U209-13. PubMed ID: 9117135
    [No Abstract]   [Full Text] [Related]  

  • 60. Cholesterol and coronary heart disease in women: an overview of primary and secondary prevention.
    Moreno GT; Manson JE
    Coron Artery Dis; 1993 Jul; 4(7):580-7. PubMed ID: 8281362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.